Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00016588 · ClinicalTrials.gov registry record · NA
Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
A NA study, sponsored by Gilead Sciences.
- Completed
- Registry status
- NA
- Development phase
NCT00016588 is a NA study that has completed, run by Gilead Sciences.
The verdict
NCT00016588, a NA study, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to look at the effectiveness of tenofovir disoproxil fumarate (TDF) in HIV-infected patients who have never taken anti-HIV drugs.
Interventions
- DRUG Tenofovir disoproxil fumarate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00016588
The ClinicalTrials.gov registry entry for NCT00016588 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tenofovir disoproxil fumarate is the first listed.
NCT00016588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00016588 about?
NCT00016588 is a clinical study titled "Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs". The purpose of this study is to look at the effectiveness of tenofovir disoproxil fumarate (TDF) in HIV-infected patients who have never taken anti-HIV drugs.
What is the current status of trial NCT00016588?
This trial is currently completed. It is a NA study. The study started on 2001-05.
What interventions are being tested in trial NCT00016588?
The interventions under investigation include: Tenofovir disoproxil fumarate (DRUG).
Who is sponsoring clinical trial NCT00016588?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.